Chronic diarrhea due to excessive bile acid synthesis and not defective ileal transport: a new syndrome of defective fibroblast growth factor 19 release.
作者信息
Hofmann Alan F, Mangelsdorf David J, Kliewer Steven A
出版信息
Clin Gastroenterol Hepatol. 2009 Nov;7(11):1151-4. doi: 10.1016/j.cgh.2009.07.026. Epub 2009 Aug 7.
Abstract
摘要
相似文献
1
Chronic diarrhea due to excessive bile acid synthesis and not defective ileal transport: a new syndrome of defective fibroblast growth factor 19 release.
Clin Gastroenterol Hepatol. 2009 Nov;7(11):1151-4. doi: 10.1016/j.cgh.2009.07.026. Epub 2009 Aug 7.
2
A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis.
Clin Gastroenterol Hepatol. 2009 Nov;7(11):1189-94. doi: 10.1016/j.cgh.2009.04.024. Epub 2009 May 6.
3
Dissecting Molecular Mechanisms in Bile Acid Diarrhea.
Am J Gastroenterol. 2016 Mar;111(3):433-5. doi: 10.1038/ajg.2016.23.
4
Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea.
Clin Gastroenterol Hepatol. 2012 Sep;10(9):1009-15.e3. doi: 10.1016/j.cgh.2012.05.006. Epub 2012 May 18.
5
Serum 7-alfa-hydroxy-4-cholesten-3-one and fibroblast growth factor-19 as biomarkers diagnosing bile acid malabsorption in microscopic colitis and inflammatory bowel disease.
Eur J Gastroenterol Hepatol. 2021 Mar 1;33(3):380-387. doi: 10.1097/MEG.0000000000001925.
6
Characterizing Factors Associated With Differences in FGF19 Blood Levels and Synthesis in Patients With Primary Bile Acid Diarrhea.
Am J Gastroenterol. 2016 Mar;111(3):423-32. doi: 10.1038/ajg.2015.424. Epub 2016 Feb 9.
7
Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder.
Expert Rev Gastroenterol Hepatol. 2010 Oct;4(5):561-7. doi: 10.1586/egh.10.54.
8
New insights into bile acid malabsorption.
Curr Gastroenterol Rep. 2011 Oct;13(5):418-25. doi: 10.1007/s11894-011-0219-3.
9
Well-compensated primary bile acid malabsorption presenting as chronic nonspecific diarrhea.
J Pediatr Gastroenterol Nutr. 1986 Jan;5(1):143-6. doi: 10.1097/00005176-198601000-00027.
10
Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature.
World J Gastroenterol. 2018 Jun 7;24(21):2320-2326. doi: 10.3748/wjg.v24.i21.2320.
引用本文的文献
1
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility.
United European Gastroenterol J. 2022 Jul;10(6):556-584. doi: 10.1002/ueg2.12259. Epub 2022 Jun 13.
2
Impact of Bile Acid Diarrhea in Patients With Diarrhea-Predominant Irritable Bowel Syndrome on Symptoms and Quality of Life.
Clin Gastroenterol Hepatol. 2022 Sep;20(9):2083-2090.e1. doi: 10.1016/j.cgh.2021.11.035. Epub 2021 Dec 4.
3
Bile Acid Diarrhea and NAFLD: Shared Pathways for Distinct Phenotypes.
Hepatol Commun. 2020 Feb 9;4(4):493-503. doi: 10.1002/hep4.1485. eCollection 2020 Apr.
4
Intestinal Absorption of Bile Acids in Health and Disease.
Compr Physiol. 2019 Dec 18;10(1):21-56. doi: 10.1002/cphy.c190007.
5
Chronic diarrhea, bile acids, and Clostridia.
J Clin Invest. 2020 Jan 2;130(1):77-79. doi: 10.1172/JCI133117.
6
A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome.
J Clin Invest. 2020 Jan 2;130(1):438-450. doi: 10.1172/JCI130976.
7
A F magnetic resonance imaging-based diagnostic test for bile acid diarrhea.
MAGMA. 2019 Feb;32(1):163-171. doi: 10.1007/s10334-018-0713-9. Epub 2018 Nov 1.
8
Attenuated Accumulation of Novel Fluorine (F)-Labeled Bile Acid Analogues in Gallbladders of Fibroblast Growth Factor-15 (FGF15)-Deficient Mice.
Mol Pharm. 2018 Nov 5;15(11):4827-4834. doi: 10.1021/acs.molpharmaceut.8b00454. Epub 2018 Oct 3.
9
Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature.
World J Gastroenterol. 2018 Jun 7;24(21):2320-2326. doi: 10.3748/wjg.v24.i21.2320.
10
Diminished gallbladder filling, increased fecal bile acids, and promotion of colon epithelial cell proliferation and neoplasia in fibroblast growth factor 15-deficient mice.
Oncotarget. 2018 May 22;9(39):25572-25585. doi: 10.18632/oncotarget.25385.
本文引用的文献
1
Bile acids: regulation of synthesis.
J Lipid Res. 2009 Oct;50(10):1955-66. doi: 10.1194/jlr.R900010-JLR200. Epub 2009 Apr 3.
2
Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.
Hepatology. 2009 Jan;49(1):297-305. doi: 10.1002/hep.22627.
3
Co-receptor requirements for fibroblast growth factor-19 signaling.
J Biol Chem. 2007 Oct 5;282(40):29069-72. doi: 10.1074/jbc.C700130200. Epub 2007 Aug 21.
4
Liver-specific activities of FGF19 require Klotho beta.
J Biol Chem. 2007 Sep 14;282(37):27277-27284. doi: 10.1074/jbc.M704244200. Epub 2007 Jul 11.
5
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members.
Mol Cell Biol. 2007 May;27(9):3417-28. doi: 10.1128/MCB.02249-06. Epub 2007 Mar 5.
6
Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption.
Eur J Gastroenterol Hepatol. 2006 Apr;18(4):397-403. doi: 10.1097/00042737-200604000-00013.
7
OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia.
Hepatology. 2005 Dec;42(6):1270-9. doi: 10.1002/hep.20961.
8
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.
Cell Metab. 2005 Oct;2(4):217-25. doi: 10.1016/j.cmet.2005.09.001.
9
Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho.
J Clin Invest. 2005 Aug;115(8):2202-8. doi: 10.1172/JCI23076.
10
New treatment for bile salt malabsorption.
Gut. 2005 Mar;54(3):441-2. doi: 10.1136/gut.2004.054486.
Zotero 插件